Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs AR 42 (Primary) ; Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 06 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 01 Mar 2013 New trial record